AR050709A1 - Metodo para preparar irbesartan e intermediarios del mismo - Google Patents

Metodo para preparar irbesartan e intermediarios del mismo

Info

Publication number
AR050709A1
AR050709A1 ARP050103520A ARP050103520A AR050709A1 AR 050709 A1 AR050709 A1 AR 050709A1 AR P050103520 A ARP050103520 A AR P050103520A AR P050103520 A ARP050103520 A AR P050103520A AR 050709 A1 AR050709 A1 AR 050709A1
Authority
AR
Argentina
Prior art keywords
compound
formula
intermediaries
same
optionally
Prior art date
Application number
ARP050103520A
Other languages
English (en)
Inventor
Edgar I Miranda
Cornelis Vlaar
Jingyang Zhu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AR050709A1 publication Critical patent/AR050709A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Un método para preparar irbesartan e intermediarios del mismo. Reivindicacion 1: Método para preparar un compuesto de formula (1), o una sal del mismo farmacéuticamente aceptable, caracterizado porque comprende hacer reaccionar una mezcla de un compuesto de la formula (2) y un compuesto de la formula (3), y opcionalmente un compuesto de formula (4) con un compuesto de formula (5), o una sal del mismo farmacéuticamente aceptable, en la presencia de una base y un agente reductor, y opcionalmente en la presencia de un catalizador de transferencia de fase; y además opcionalmente, convertir el compuesto de la formula (1) en una sal farmacéuticamente aceptable.
ARP050103520A 2004-08-23 2005-08-22 Metodo para preparar irbesartan e intermediarios del mismo AR050709A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60360604P 2004-08-23 2004-08-23

Publications (1)

Publication Number Publication Date
AR050709A1 true AR050709A1 (es) 2006-11-15

Family

ID=35968277

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050103520A AR050709A1 (es) 2004-08-23 2005-08-22 Metodo para preparar irbesartan e intermediarios del mismo

Country Status (21)

Country Link
US (2) US7211676B2 (es)
EP (1) EP1781627B1 (es)
JP (1) JP5203703B2 (es)
KR (1) KR101252309B1 (es)
CN (1) CN101006064B (es)
AR (1) AR050709A1 (es)
AT (1) ATE488508T1 (es)
AU (1) AU2005277162B2 (es)
BR (1) BRPI0514584A (es)
CA (2) CA2578409A1 (es)
DE (1) DE602005024819D1 (es)
ES (1) ES2357393T3 (es)
HK (1) HK1098157A1 (es)
IL (1) IL181464A (es)
MX (1) MX2007002030A (es)
NO (1) NO20071254L (es)
PE (1) PE20060650A1 (es)
RU (1) RU2388753C2 (es)
TW (1) TWI346108B (es)
WO (1) WO2006023889A2 (es)
ZA (1) ZA200701363B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1918288A1 (en) 2006-11-02 2008-05-07 Cadila Pharmaceuticals Limited A novel and improved process for the preparation of Irbesartan, an angiotensin-II receptor antagonist for the treatment of hypertension
GB0700993D0 (en) * 2007-01-18 2007-02-28 Rainbow Engineering Services Novel compounds
US20100063299A1 (en) * 2007-03-06 2010-03-11 Udhaya Kumar Process for Preparing Irbesartan
SI22488A (sl) * 2007-04-24 2008-10-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalni 1-(cikloheksiloksikarboniloksi)etil 1-((2'-cianobifenil-4-il)metil) - 2-etoksi-1h-benz(d)imidazol -7-karboksilat in proces za njegovo pripravo
HUP0900788A2 (en) * 2009-12-16 2011-11-28 Sanofi Aventis Process for producing 4-bromomethyl-biphenyl derivatives
WO2011111831A1 (ja) * 2010-03-12 2011-09-15 日本曹達株式会社 ピリジン環含有化合物、及びハロゲン化ピコリン誘導体及びテトラゾリルオキシム誘導体の製造方法
CN102807564A (zh) * 2012-08-30 2012-12-05 珠海润都制药股份有限公司 厄贝沙坦的制备方法
CN102898420B (zh) * 2012-09-10 2014-10-29 珠海保税区丽珠合成制药有限公司 一种厄贝沙坦的合成路线及制备方法
CN103497178B (zh) * 2013-09-27 2015-04-08 中国药科大学 厄贝沙坦瑞格列奈共无定型物
CN104744303B (zh) * 2015-02-15 2017-06-23 北京欣奕华科技有限公司 2‑r‑4’‑溴甲基联苯及其制备方法
CN108164434A (zh) * 2017-12-27 2018-06-15 安徽太主科技发展有限公司 一种低成本4′-溴甲基-2-氰基联苯的制备方法
US11655220B2 (en) 2020-10-22 2023-05-23 Hetero Labs Limited Process for the preparation of angiotensin II receptor blockers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
PT97078B (pt) * 1990-03-20 1997-07-31 Sanofi Sa Processo para a preparacao de derivados heterociclicos n-substituidos e de composicoes farmaceuticas que os contem
US5541209A (en) 1994-08-22 1996-07-30 Bristol-Myers Squibb Company Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
FR2725987B1 (fr) * 1994-10-19 1997-01-10 Sanofi Sa Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
JP3003030B2 (ja) * 1997-05-26 2000-01-24 武田薬品工業株式会社 アミノベンゼン化合物の製造法
FR2766821A1 (fr) 1997-07-29 1999-02-05 Sanofi Sa Derives de 1,3-oxazolinyl-biphenyle, leur procede de preparation et leur utilisation comme intermediaires de synthese
US6162922A (en) * 1998-01-30 2000-12-19 Bristol-Myers Squibb Co. Method for preparing N-substituted heterocyclic derivatives using a phase-transfer catalyst
FR2780403B3 (fr) 1998-06-24 2000-07-21 Sanofi Sa Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
CN100418962C (zh) * 2002-10-28 2008-09-17 南京长澳医药科技有限公司 一种厄贝沙坦合成工艺
CN101165062A (zh) * 2003-01-16 2008-04-23 特瓦制药工业有限公司 伊贝沙坦的新合成方法

Also Published As

Publication number Publication date
MX2007002030A (es) 2007-03-28
ATE488508T1 (de) 2010-12-15
CN101006064B (zh) 2011-01-26
JP5203703B2 (ja) 2013-06-05
TWI346108B (en) 2011-08-01
US7211676B2 (en) 2007-05-01
HK1098157A1 (en) 2007-07-13
WO2006023889A3 (en) 2006-09-08
DE602005024819D1 (de) 2010-12-30
EP1781627A2 (en) 2007-05-09
TW200619205A (en) 2006-06-16
RU2007109330A (ru) 2008-09-27
NO20071254L (no) 2007-03-22
AU2005277162B2 (en) 2010-12-16
IL181464A (en) 2011-08-31
IL181464A0 (en) 2007-07-04
CA2754633A1 (en) 2006-03-02
AU2005277162A1 (en) 2006-03-02
KR20070045275A (ko) 2007-05-02
CN101006064A (zh) 2007-07-25
RU2388753C2 (ru) 2010-05-10
JP2008510819A (ja) 2008-04-10
ZA200701363B (en) 2008-06-25
US7365208B2 (en) 2008-04-29
WO2006023889A2 (en) 2006-03-02
US20060041147A1 (en) 2006-02-23
EP1781627A4 (en) 2009-09-02
ES2357393T3 (es) 2011-04-26
BRPI0514584A (pt) 2008-06-17
US20070167634A1 (en) 2007-07-19
PE20060650A1 (es) 2006-07-09
EP1781627B1 (en) 2010-11-17
KR101252309B1 (ko) 2013-04-08
CA2578409A1 (en) 2006-03-02

Similar Documents

Publication Publication Date Title
AR050709A1 (es) Metodo para preparar irbesartan e intermediarios del mismo
MY139475A (en) Process for the preparation of (1s)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane, acid addition salts thereof and its use for the synthesis of ivabradine and for its pharmaceutically acceptable acid addition salts
AR049681A1 (es) Macrolidos preparados a partir de actinomicetos. composiciones farmaceuticas
CR11780A (es) Nuevo proceso para la sintesis de ivabradina y sales de adicion resultantes con un acido farmaceuticamente aceptable (solicitud divisonal)
AR050518A1 (es) Proceso de amonolisis para la preparacion de intermedarios para inhibidores de dpp iv
DOP2006000170A (es) Nuevos derivados de espirocromanona
ATE441630T1 (de) Substituierte cyclopenten-verbindungen
CL2009000882A1 (es) Un compuesto n-(4-cloro-3-(piridin-2-il)fenil)-4-(2-hidroxi-2-metilpropilsulfonil)-2-metilbenzamida, inhibidor de la via de señalización hedgehog; composición farmacéutica que comprende a dicho compuesto; y su uso para tratar el cancer.
AR077416A2 (es) Compuesto polimorfo estable de flibanserina , procedimiento industrial para su preparacion y uso del mismo para preparar medicamentos
CY1114793T1 (el) Παραγωγα αμινοπυραζολιου
AR069493A1 (es) Mejora del proceso usando tmeda
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
MY153985A (en) Aminotriazole derivatives as alx agonists
MX2007005933A (es) Compuestos de acetamida como fungicidas.
CL2010000516A1 (es) Composicion fungicida sin solvente que comprende estrobirulina insoluble en agua dispersado a traves del material portador en forma nano-dispersa teniendo un diametro pico de la forma nano-dispersa menor a 1000 nm; proceso para preparar dicha composicion; uso de dicha composicion para tratar una infestacion (divisional de la sol. 2030-07).
AR049274A1 (es) Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2
AR073524A1 (es) Piridopirimidinonas inhibidores de pi3k a y m tor
CL2009001414A1 (es) Procedimiento de sintesis de 7,8-dimetoxi-1,3-dihidro-2h-3-benzazepin-2-ona sin aislacion de compuestos intermediarios; util para la sintesis de ivabradina.
UY31460A1 (es) Procedimiento de preparacion de compuestos morfinicos
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
AR039935A1 (es) Formulacion farmaceutica de liberacion inmediata
PA8646301A1 (es) Inhibidores de la adenilato ciclasa soluble
SV2009003168A (es) Derivados de oxazolidona como moduladores pr

Legal Events

Date Code Title Description
FC Refusal